GLP-1 Medicines and Kidney Disease: What Patients With CKD Need to Know Before Starting Ozempic, Wegovy, or Mounjaro

GLP-1 medications such as semaglutide and tirzepatide may help patients with chronic kidney disease lose weight and improve metabolic health. But nephrologists warn that dehydration and gastrointestinal side effects can increase the risk of acute kidney injury in vulnerable patients.

Semaglutide and Acute Kidney Injury: Why Dehydration Is the Real Threat Behind Some GLP-1 Kidney Complications

Semaglutide is increasingly recognized for protecting kidney function in type 2 diabetes, yet rare cases of acute kidney injury continue to emerge. The primary culprit is usually severe dehydration caused by gastrointestinal side effects, not direct kidney toxicity.